Abstract: The present invention relates to a compound of general formula (I) or a pharmaceutically acceptable salt and/or solvate thereof. The invention further relates to the use of the compounds of the invention as neuroprotective and/or neurorestorative agents, in particular for use in the treatment of neurological disorders.
| # | Name | Date |
|---|---|---|
| 1 | 202517030005-STATEMENT OF UNDERTAKING (FORM 3) [28-03-2025(online)].pdf | 2025-03-28 |
| 3 | 202517030005-Sequence Listing in PDF [28-03-2025(online)].pdf | 2025-03-28 |
| 4 | 202517030005-REQUEST FOR EXAMINATION (FORM-18) [28-03-2025(online)].pdf | 2025-03-28 |
| 5 | 202517030005-PRIORITY DOCUMENTS [28-03-2025(online)].pdf | 2025-03-28 |
| 6 | 202517030005-FORM 18 [28-03-2025(online)].pdf | 2025-03-28 |
| 7 | 202517030005-FORM 1 [28-03-2025(online)].pdf | 2025-03-28 |
| 8 | 202517030005-DECLARATION OF INVENTORSHIP (FORM 5) [28-03-2025(online)].pdf | 2025-03-28 |
| 9 | 202517030005-COMPLETE SPECIFICATION [28-03-2025(online)].pdf | 2025-03-28 |
| 10 | 202517030005-Proof of Right [28-06-2025(online)].pdf | 2025-06-28 |
| 11 | 202517030005-FORM-26 [28-06-2025(online)].pdf | 2025-06-28 |
| 12 | 202517030005-FORM 3 [29-07-2025(online)].pdf | 2025-07-29 |